Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jorgensen

Showing results (471-480 of 567) with videos related to

Pageof 57
Sort By:
Oncotarget|May 21, 2016
Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphomaShaoying Li, Annapurna Saksena, Parth Desai, et al.
Pharmacogenomics|December 19, 2007
The association between polymorphisms in RLIP76 and drug response in epilepsyGuy D Leschziner, Andrea L Jorgensen, Toby Andrew, et al.
RSC Pharmaceutics|October 7, 2024
Prodrug nanotherapy demonstrates <i>in vivo</i> anticryptosporidial efficacy in a mouse model of chronic <i>Cryptosporidium</i> infectionAmalendu P Ranjan, Daniel J Czyzyk, Griselle Martinez-Traverso, et al.
The Lancet. Neurology|July 22, 2006
Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort studyGuy Leschziner, Andrea L Jorgensen, Toby Andrew, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2014
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populationsDaniel F Carr, Mas Chaponda, Elena M Cornejo Castro, et al.
Leukemia|May 3, 2023
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRDPhilip A Thompson, Michael J Keating, Alessandra Ferrajoli, et al.
Archives of Pathology & Laboratory Medicine|December 23, 2024
The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic SyndromesFnu Sameeta, Wei Wang, Fatima Zahra Jelloul, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2024
Proof-of-concept studies with a computationally designed M<sup>pro</sup> inhibitor as a synergistic combination regimen alternative to PaxlovidChristina Papini, Irfan Ullah, Amalendu P Ranjan, et al.
Oncotarget|March 2, 2018
Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencingAndrés E Quesada, Zhihong Hu, Mark J Routbort, et al.
The American Journal of Surgical Pathology|April 11, 2018
Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid NeoplasmsHabibe Kurt, Carlos E Bueso-Ramos, Joseph D Khoury, et al.
Pageof 57

Showing results (471-480 of 567) with videos related to

Sort By:
Pageof 57
Oncotarget|May 21, 2016
Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphomaShaoying Li, Annapurna Saksena, Parth Desai, et al.
Pharmacogenomics|December 19, 2007
The association between polymorphisms in RLIP76 and drug response in epilepsyGuy D Leschziner, Andrea L Jorgensen, Toby Andrew, et al.
RSC Pharmaceutics|October 7, 2024
Prodrug nanotherapy demonstrates <i>in vivo</i> anticryptosporidial efficacy in a mouse model of chronic <i>Cryptosporidium</i> infectionAmalendu P Ranjan, Daniel J Czyzyk, Griselle Martinez-Traverso, et al.
The Lancet. Neurology|July 22, 2006
Clinical factors and ABCB1 polymorphisms in prediction of antiepileptic drug response: a prospective cohort studyGuy Leschziner, Andrea L Jorgensen, Toby Andrew, et al.
The Journal of Antimicrobial Chemotherapy|August 23, 2014
CYP2B6 c.983T>C polymorphism is associated with nevirapine hypersensitivity in Malawian and Ugandan HIV populationsDaniel F Carr, Mas Chaponda, Elena M Cornejo Castro, et al.
Leukemia|May 3, 2023
Venetoclax consolidation in high-risk CLL treated with ibrutinib for ≥1 year achieves a high rate of undetectable MRDPhilip A Thompson, Michael J Keating, Alessandra Ferrajoli, et al.
Archives of Pathology & Laboratory Medicine|December 23, 2024
The Significance of Detecting an Unusual Myeloblast Immunophenotype in a Presumptive Clinical Diagnosis of Myelodysplastic SyndromesFnu Sameeta, Wei Wang, Fatima Zahra Jelloul, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 2024
Proof-of-concept studies with a computationally designed M<sup>pro</sup> inhibitor as a synergistic combination regimen alternative to PaxlovidChristina Papini, Irfan Ullah, Amalendu P Ranjan, et al.
Oncotarget|March 2, 2018
Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencingAndrés E Quesada, Zhihong Hu, Mark J Routbort, et al.
The American Journal of Surgical Pathology|April 11, 2018
Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid NeoplasmsHabibe Kurt, Carlos E Bueso-Ramos, Joseph D Khoury, et al.
Pageof 57